KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Receivables (2016 - 2026)

ClearPoint Neuro's Receivables history spans 14 years, with the latest figure at $6.7 million for Q4 2025.

  • On a quarterly basis, Receivables rose 42.14% to $6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.7 million, a 42.14% increase, with the full-year FY2025 number at $6.7 million, up 42.14% from a year prior.
  • Receivables hit $6.7 million in Q4 2025 for ClearPoint Neuro, up from $5.3 million in the prior quarter.
  • Over the last five years, Receivables for CLPT hit a ceiling of $6.7 million in Q4 2025 and a floor of $200000.0 in Q3 2021.
  • Historically, Receivables has averaged $3.4 million across 5 years, with a median of $3.1 million in 2023.
  • Biggest five-year swings in Receivables: crashed 86.8% in 2021 and later surged 1605.5% in 2022.
  • Tracing CLPT's Receivables over 5 years: stood at $2.4 million in 2021, then grew by 22.77% to $3.0 million in 2022, then increased by 7.32% to $3.2 million in 2023, then skyrocketed by 46.78% to $4.7 million in 2024, then soared by 42.14% to $6.7 million in 2025.
  • Business Quant data shows Receivables for CLPT at $6.7 million in Q4 2025, $5.3 million in Q3 2025, and $4.8 million in Q2 2025.